NSEAcquisition30 Jun 2026 · 30 Jun 2026, 09:57 am

Acquisition

Aurobindo Pharma Limited · AUROPHARMA

✦ AI Summary▲ PositiveM&A

Aurobindo Pharma Limited has completed the acquisition of Lannett Company, Inc. through its US subsidiary, Aurobindo Pharma USA Inc.

Analysis Scores

Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Intimation of completion of Lannett acquisition by Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company.

Attachments (1)

📄

AUROPHARMA_30062026095710_LtrToSEsLannettAcquistionCompletion30062026.pdf

pdf

Download →
View document text
June 30, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Phiroz Jeejeebhoy Towers, 25th floor, Dalal MUMBAI -400 051 Street, MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Ref: Our letter dated June 19, 2026, and press release dated June 22, 2026 Aurobindo Pharma USA Inc., (APUSA), a wholly owned subsidiary of Aurobindo Pharma Limited, is pleased to announce the successful completion of its acquisition of Lannett Company, Inc., USA (“Lannett”), from Lannett Seller Holdco, Inc., following receipt of approval from the U.S. Federal Trade Commission on June 18, 2026. Effective June 29, 2026, Lannett has become a wholly owned subsidiary of APUSA and will operate as Lannett Company LLC. The integration process will commence immediately, with a strong emphasis on ensuring uninterrupted access to critical medications, maintaining trusted relationships with partners, and supporting employees throughout the transition. By combining capabilities and resources, the organization aims to enhance the availability of essential medicines and deliver sustained, long-term value to patients, customers, and stakeholders. APUSA is also pleased to welcome more than 400 Lannett employees to its organization, further strengthening its talent base and operational capabilities. We extend our sincere appreciation to Lannett’s management team for their leadership in enabling a smooth transition, as well as for their valuable contributions to the organization. Please take the above information on record. Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana., India. Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com